MedPath

Methimazole

METHIMAZOLE TABLETS, USP

Approved
Approval ID

68942ec1-763a-4757-96ad-0e749aba348c

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 27, 2020

Manufacturers
FDA

ECI Pharmaceuticals, LLC

DUNS: 962476029

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Methimazole

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code51293-820
Application NumberANDA040547
Product Classification
M
Marketing Category
C73584
G
Generic Name
Methimazole
Product Specifications
Route of AdministrationORAL
Effective DateMay 13, 2017
FDA Product Classification

INGREDIENTS (5)

METHIMAZOLEActive
Quantity: 5 mg in 1 1
Code: 554Z48XN5E
Classification: ACTIB
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
STARCH, POTATOInactive
Code: 8I089SAH3T
Classification: IACT

Methimazole

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code51293-821
Application NumberANDA040547
Product Classification
M
Marketing Category
C73584
G
Generic Name
Methimazole
Product Specifications
Route of AdministrationORAL
Effective DateMay 13, 2017
FDA Product Classification

INGREDIENTS (5)

METHIMAZOLEActive
Quantity: 10 mg in 1 1
Code: 554Z48XN5E
Classification: ACTIB
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
STARCH, POTATOInactive
Code: 8I089SAH3T
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Methimazole - FDA Drug Approval Details